VOTRIENT 200 mg/1
pazopanib hydrochloride · TABLET, FILM COATED · Novartis Pharmaceuticals Corporation
No Recall History
Plain English
VOTRIENT is a tablet, film coated containing pazopanib hydrochloride at 200 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- VOTRIENT
- Generic Name
- pazopanib hydrochloride
- NDC Code (Product)
0078-1077- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA022465
- Marketing Start
- 07/12/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is VOTRIENT used for?
VOTRIENT contains pazopanib hydrochloride. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is VOTRIENT a controlled substance?
VOTRIENT is not classified as a controlled substance by the DEA.
What is the generic name for VOTRIENT?
The generic name for VOTRIENT is pazopanib hydrochloride. There are 2 other brand versions of pazopanib hydrochloride.
What is the NDC code for VOTRIENT 200 mg/1?
The NDC (National Drug Code) for VOTRIENT 200 mg/1 is 0078-1077, listed by Novartis Pharmaceuticals Corporation.